// App-Quantinova.ai

MEDU-12 : CD271 (p75NTR) as a novel diagnostic marker and therapeutic target for SHH medulloblastoma

Researchers

Presenter

  • Ludivine Coudiere-Morrison

Principal Investigators

  • Nazanin Tatari

  • Vijay Ramaswamy

  • Timothy Ryken

  • Marc Del Bigio

  • Cynthia Hawkins

  • Jennifer Chan

  • Tamra Werbowetski-Ogilvie

Medical Centers

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Arthur and Sonia Labatt Brain Tumour Research Centre and Program in Developmental and Stem Cell Biology, Toronto, ON, Canada,

  • Hospital for Sick Children, Toronto, ON, Canada

  • University of Kansas, Kansas City, KS

  • University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Nuclear factor kappa-light-chain-enhancer of activated B cells

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • cMYC

  • Janus kinase

  • PI3K/AKT

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved